Retraction: Silencing of APE1 Enhances Sensitivity of Human Hepatocellular Carcinoma Cells to Radiotherapy In Vitro and in a Xenograft Model (PLoS ONE (2013) 8:2 (e55313) DOI: 10.1371/journal.pone.0055313);Silencing of APE1 Enhances Sensitivity of Human Hepatocellular Carcinoma Cells to Radiotherapy In Vitro and in a Xenograft Model

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Cun, Yanping ^a   Dai, Nan ^a   Xiong, Chengjie ^b   Li, Mengxia ^a   Sui, Jiangdong ^a   Qian, Chengyuan ^a   Li, Zheng ^a   Wang, Dong ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; DNA (APURINIC OR APYRIMIDINIC SITE) LYASE; ENHANCED GREEN FLUORESCENT PROTEIN; PROTEIN P53; SMALL INTERFERING RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL MUTANT; CELL STRAIN HEP3B; CELL STRAIN HEPG2; CELL STRAIN MHCC97L; CELL SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; IRRADIATION; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; PROTEIN EXPRESSION; RADIATION DOSE; RADIOSENSITIVITY; TUMOR XENOGRAFT; VIRAL GENE DELIVERY SYSTEM;

EID: 84873917121     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0292822     Document Type: Erratum

References (45)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, et al. (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127(12): 2893-2917.
2. Siegel R, Naishadham D, Jemal A, (2012) Cancer statistics, 2012. CA Cancer J Clin 62(1): 10-29.
3. McGlynn KA, Tsao L, Hsing AW, Devesa SS, Fraumeni Jr JF, (2001) International trends and patterns of primary liver cancer. Int J Cancer 94(2): 290-296.
4. Toya R, Murakami R, Baba Y, Nishimura R, Morishita S, et al. (2007) Conformal radiation therapy for portal vein tumor thrombosis of hepatocellular carcinoma. Radiother Oncol 84(3): 266-271.
5. Rodemann HP, (2009) Molecular radiation biology: perspectives for radiation oncology. Radiother Oncol 92(3): 293-298.
6. Herring CJ, West CM, Wilks DP, Davidson SE, Hunter RD, et al. (1998) Levels of the DNA repair enzyme human apurinic/apyrimidinic endonuclease (APE1, APEX, Ref-1) are associated with the intrinsic radiosensitivity of cervical cancers. Br J Cancer 78(9): 1128-1133.
7. Robertson KA, Bullock HA, Xu Y, Tritt R, Zimmerman E, et al. (2001) Altered expression of Ape1/ref-1 in germ cell tumors and overexpression in NT2 cells confers resistance to bleomycin and radiation. Cancer Res 61(5): 2220-2225.
8. Jayaraman L, Murthy KG, Zhu C, Curran T, Xanthoudakis S, et al. (1997) Identification of redox/repair protein Ref-1 as a potent activator of p53. Genes Dev 11(5): 558-570.
9. Hanson S, Kim E, Deppert W, (2005) Redox factor 1 (Ref-1) enhances specific DNA binding of p53 by promoting p53 tetramerization. Oncogene 24(9): 1641-1647.
10. Vousden KH, Lane DP, (2007) p53 in health and disease. Nat Rev Mol Cell Biol 8(4): 275-283.
11. Lai PBS, Chi TY, Chen GG, (2007) Different levels of p53 induced either apoptosis or cell cycle arrest in a doxycycline-regulated hepatocellular carcinoma cell line in vitro. Apoptosis 12(2): 387-393.
12. He M, Zhao M, Shen B, Prise KM, Shao C, (2011) Radiation-induced intercellular signaling mediated by cytochrome-c via a p53-dependent pathway in hepatoma cells. Oncogene 30(16): 1947-1955.
13. Concin N, Zeillinger C, Stimpfel M, Schiebel I, Tong D, et al. (2000) p53-dependent radioresistance in ovarian carcinoma cell lines. Cancer Lett 150(2): 191-199.
14. Puisieux A, Galvin K, Troalen F, Bressac B, Marcais C, et al. (1993) Retinoblastoma and p53 tumor suppressor genes in human hepatoma cell lines. Faseb J 7(14): 1407-1413.
15. You KR, Wen J, Lee ST, Kim DG, (2002) Cytochrome c oxidase subunit III: a molecular marker for N-(4-hydroxyphenyl)retinamise-induced oxidative stress in hepatoma cells. J Biol Chem 277(6): 3870-3877.
16. Ng LT, Chiang LC, Lin YT, Lin CC, (2006) Antiproliferative and apoptotic effects of tetrandrine on different human hepatoma cell lines. Am J Chin Med 34(1): 125-135.
17. Bressac B, Kew M, Wands J, Ozturk M, (1991) Selective G to T mutations of p 53 gene in hepatocellular carcinoma from southern Africa. Nature 350(6317): 429-431.
18. Dumenco L, Oguey D, Wu J, Messier N, Fausto N, (1995) Introduction of a murine p53 mutation corresponding to human codon 249 into a murine hepatocyte cell line results in growth advantage, but not in transformation. Hepatology 22(4): 1279-1288.
19. Forrester K, Lupold SE, Ott VL, Chay CH, Band V, et al. (1995) Effects of p53 mutants on wild-type p53-mediated transactivation are cell type dependent. Oncogene 10(11): 2103-2111.
20. Schindl M, Oberhuber G, Pichlbauer EG, Obermair A, Birner P, et al. (2001) DNA repair-redox enzyme apurinic endonuclease in cervical cancer: Evaluation of redox control of HIF-La and prognostic significance. Int J Oncol 19(4): 799-802.
21. Tanner B, Grimme S, Schiffer I, Heimerdinger C, Schmidt M, et al. (2004) Nuclear expression of apurinic/apyrimidinic endonuclease increases with progression of ovarian carcinomas. Gynecol Oncol 92(2): 568-577.
22. Wang D, Luo M, Kelley MR, (2004) Human apurinic endonuclease 1 (APE1) expression and prognostic significance in osteosarcoma: enhanced sensitivity of osteosarcoma to DNA damaging agents using silencing RNA APE1 expression inhibition. Mol Cancer Ther 3(6): 679-686.
23. Xiang DB, Chen ZT, Wang D, Li MX, Xie JY, et al. (2008) Chimeric adenoviral vector Ad5/F35-mediated APE1 siRNA enhances sensitivity of human colorectal cancer cells to radiotherapy in vitro and in vivo. Cancer Gene Ther 15(10): 625-635.
24. Yoo DG, Song YJ, Cho EJ, Lee SK, Park JB, et al. (2008) Alteration of APE1/ref-1 expression in non-small cell lung cancer: the implications of impaired extracellular superoxide dismutase and catalase antioxidant systems. Lung cancer 60(2): 277-284.
25. Di Maso V, Avellini C, Croce LS, Rosso N, Quadrifoglio F, et al. (2007) Subcellular localization of APE1/Ref-1 in human hepatocellular carcinoma: possible prognostic significance. Mol Med 13(1-2): 89-96.
26. Chen DS, Olkowski ZL, (1994) Biological Responses of Human Apurinic Endonuclease to Radiation-Induced DNA Damage. Ann N Y Acad Sci 726(1): 306-308.
27. Wang D, Zhong ZY, Li MX, Xiang DB, Li ZP, (2007) Vector-based Ape1 small interfering RNA enhances the sensitivity of human osteosarcoma cells to endostatin in vivo. Cancer Sci 98(12): 1993-2001.
28. Singh PK, Kumar R, Sharma A, Arora R, Chawla R, et al. (2011) Role of Apoptotic Proteins in REC-2006 Mediated Radiation Protection in Hepatoma Cell Lines. Evid Based Complement Alternat Med 2011: 758326.
29. Jia JB, Wang WQ, Sun HC, Liu L, Zhu XD, et al. (2011) A novel tripeptide, tyroserleutide, inhibits irradiation-induced invasiveness and metastasis of hepatocellular carcinoma in nude mice. Invest New Drugs 29(5): 861-872.
30. Di Bisceglie AM, (2004) Issues in screening and surveillance for hepatocellular carcinoma. Gastroenterology 127(5): S104-S107.
31. Jakobs TF, Hoffmann RT, Tatsch K, Trumm C, Reiser MF, (2008) [Therapy response of liver tumors after selective internal radiation therapy]. Radiologe 48(9): 839-849.
32. Yang W, Sun T, Cao J, Liu F, (2010) Survivin downregulation by siRNA/cationic liposome complex radiosensitises human hepatoma cells in vitro and in vivo. Int J Radiat Biol 86(6): 445-457.
33. Madhusudan S, Middleton MR, (2005) The emerging role of DNA repair proteins as predictive, prognostic and therapeutic targets in cancer. Cancer Treat Rev 31(8): 603-617.
34. Belzile JP, Choudhury SA, Cournoyer D, Chow TYK, (2006) Targeting DNA repair proteins: a promising avenue for cancer gene therapy. Curr Gene Ther 6(1): 111-123.
35. Ding J, Miao ZH, Meng LH, Geng MY, (2006) Emerging cancer therapeutic opportunities target DNA-repair systems. Trends Pharmacol Sci 27(6): 338-344.
36. Fishel ML, Kelley MR, (2007) The DNA base excision repair protein Ape1/Ref-1 as a therapeutic and chemopreventive target. Mol Aspects Med 28(3-4): 375-395.
37. Fan J, Wilson DM, (2005) Protein-protein interactions and posttranslational modifications in mammalian base excision repair. Free Radic Biol Med 38(9): 1121-1138.
38. Tell G, Quadrifoglio F, Tiribelli C, Kelley MR, (2009) The many functions of APE1/Ref-1: not only a DNA repair enzyme. Antioxid Redox Signal 11(3): 601-619.
39. Zurer I, Hofseth LJ, Cohen Y, Xu-Welliver M, Hussain SP, et al. (2004) The role of p53 in base excision repair following genotoxic stress. Carcinogenesis 25(1): 11-19.
40. Helton ES, Chen X, (2007) p53 modulation of the DNA damage response. J Cell Biochem 100(4): 883-896.
41. Oren M, Rotter V, (2010) Mutant p53 gain-of-function in cancer. Cold Spring Harb Perspect Biol 2(2): a001107.
42. Komarov PG, Komarova EA, Kondratov RV, Christov-Tselkov K, Coon JS, et al. (1999) A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. Science 285(5434): 1733-1737.
43. Zhang XP, Liu F, Cheng Z, Wang W, (2009) Cell fate decision mediated by p53 pulses. Proc Nati Acad Sci 106(30): 12245-12250.
44. Viani P, Giussani P, Brioschi L, Bassi R, Anelli V, et al. (2003) Ceramide in Nitric Oxide Inhibition of Glioma Cell Growth. J Biol Chem 278(11): 9592-9601.
45. Yang ZZ, Chen XH, Wang D, (2007) Experimental study enhancing the chemosensitivity of multiple myeloma to melphalan by using a tissue-specific APE1-silencing RNA expression vector. Clin Lymphoma Myeloma 7(4): 296-304.